A novel oxygen carrier “YQ23” suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells

BACKGROUND: Surgical therapies are the first-line treatments for hepatocellular carcinoma (HCC) patients. However, the high incidence of tumor metastasis after liver surgery remains a severe problem. We aim to investigate the roles and the underlying mechanism of YQ23, stabilized non-polymeric diasp...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chang Xian, Wong, Bing L, Ling, Chang Chun, Ma, Yuen Yuen, Shao, Yan, Geng, Wei, Qi, Xiang, Lau, Sze Hang, Kwok, Sui Yi, Wei, Na, Tzang, Fei Chuen, Ng, Kevin TP, Liu, Xiao Bing, Lo, Chung Mau, Man, Kwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006450/
https://www.ncbi.nlm.nih.gov/pubmed/24766798
http://dx.doi.org/10.1186/1471-2407-14-293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006450/
https://www.ncbi.nlm.nih.gov/pubmed/24766798
http://dx.doi.org/10.1186/1471-2407-14-293

Ejemplares similares